Regulatory UK regulators greenlight Lilly’s Foundayo, intensifying Novo competition Pharmaceutical TechnologyThe MHRA is the first European regulator to give Foundayo a regulatory blessing, with the drug still under review by the EU.Metabolic & GLP-1Read full story pharminent August 11, 2026 (Last updated: August 14, 2026) Pharmaceutical Technology The MHRA is the first European regulator to give Foundayo a regulatory blessing, with the drug still under review by the EU. Metabolic & GLP-1 Read full story Post navigation Previous: BMS banks on Texas for $2.3bn multi-modal manufacturing facilityNext: Trump signs order that nearly halves childhood immunisation coverage Related Stories Regulatory FDA clears Takeda, Protagonist’s first-in-class PV drug pharminent August 31, 2026 Regulatory FDA green lights Priovant drug for rare skin disease pharminent August 28, 2026 Regulatory Neurocrine receives FDA IND Acceptance for Alzheimer’s Ph2 pharminent August 26, 2026